Medication info

Exator Table 5/160/10 milligrams

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›160mg / 1 tabletAtorvastatin Calcium Hydrate›10.85mg / 1 tablet
Manufacturer / importer
Korea Hutech Pharmaceutical Co., Ltd.
Appearance
Light yellowish-brown oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202105300 · Approved 2021.07.12 · Insurance code 649105340

Summary

Main use
Treatment of essential hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. - Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. - Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.

Ingredients

Manufacturer
Korea Hutech Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease

  • Essential hypertension
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • dyslipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • primary familial hypobetalipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by taking a combination of amlodipine and valsartan, and in patients who require treatment for dyslipidemia and risk reduction of cardiovascular disease through atorvastatin. The amlodipine/valsartan combination helps with blood pressure control, while atorvastatin reduces the risk of myocardial infarction, stroke, vascular surgery, and angina. Additionally, atorvastatin improves cholesterol and triglyceride levels in patients with hypercholesterolemia and dyslipidemia, supporting cardiovascular health. By taking these two medications simultaneously, blood pressure and blood lipid levels can be effectively managed. Therefore, this drug is used for the reduction of hypertension and cardiovascular disease risk, as well as the improvement of dyslipidemia.

How to take

Adult dose

Take 1 tablet once daily with water. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. - Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. - Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Furthermore, if muscle-related abnormal symptoms or a significant increase in creatine kinase levels occur during the course of treatment, therapy should be stopped immediately. Some patients, such as those with severe liver or kidney impairment, certain genetic disorders, or women who are pregnant or breastfeeding, should not use this medication. Patients with a deficiency of sodium or fluid in the body, hyperkalemia, those who have undergone kidney transplantation, or patients with heart failure should use this medication with special caution; regular monitoring of blood pressure, kidney function, electrolyte levels, etc., is required during treatment. This medication may cause various side effects, including dizziness, headache, gastrointestinal disturbances, and swelling, so if any unusual symptoms appear, one should consult a doctor immediately. Additionally, there may be dizziness or drowsiness while driving or operating machinery, so caution is necessary. This medication may interact with other drugs, so if you are taking other medications, you must inform your healthcare provider. In particular, the risk of side effects may increase when used in combination with certain antibiotics, antifungals, immunosuppressants, and some antiviral drugs. Women who are pregnant or planning to become pregnant should not take this medication, and women of childbearing age should use appropriate contraception while taking this medication. It is also recommended that breastfeeding women do not take this medication. It is essential to consult a doctor or pharmacist before use to confirm the appropriate use and precautions suitable for individual health conditions.

Side effects

  • Dry eye
  • nausea
  • headache
  • nasopharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • dizziness
  • drowsiness
Show 137 more
  • positional dizziness
  • sensory disturbances
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • throat and laryngeal pain
  • diarrhea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • sweating
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle cramps
  • weakness
  • increased urination
  • polyuria
  • erectile dysfunction
  • edema
  • localized edema
  • facial edema
  • peripheral edema
  • fatigue
  • flushing
  • asthenia
  • facial flushing
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • taste disturbances
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • angioedema
  • urticaria
  • erythema multiforme
  • myalgia
  • urination disorders
  • nocturia
  • gynecomastia
  • pain
  • malaise
  • weight loss
  • weight gain
  • hemoglobin decrease
  • hematocrit decrease
  • neutropenia
  • serological disease
  • hyperkalemia
  • vasculitis
  • elevated liver function tests
  • vesicular dermatitis
  • renal failure
  • kidney damage
  • elevated serum creatinine
  • fatigue
  • chest pain
  • tiredness
  • fever
  • hyperglycemia
  • hypoglycemia
  • weight gain
  • appetite loss
  • vomiting
  • dyspepsia
  • pancreatitis
  • throat and laryngeal pain
  • nosebleeds
  • nightmares
  • perceptual disturbances
  • amnesia
  • peripheral neuropathy
  • muscle spasms
  • muscle fatigue
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • anaphylaxis
  • cholestasis
  • liver failure
  • blurred vision
  • tinnitus
  • hearing loss
  • angioneurotic edema
  • skin-mucous membrane syndrome
  • thrombocytopenia
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • gynecomastia
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux disease
  • neck pain
  • hypercholesterolemia
  • hypoglycemia
  • nocturia
  • arthralgia
  • skeletal pain
  • rhabdomyolysis
  • gingival hyperplasia
  • gastritis
  • hypersensitivity
  • sensory loss
  • Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture and should be stored at a cool room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellowish-brown oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.